1-42381055-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173642.4(RIMKLA):āc.121C>Gā(p.Leu41Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000258 in 1,162,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173642.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIMKLA | NM_173642.4 | c.121C>G | p.Leu41Val | missense_variant | 1/5 | ENST00000431473.4 | NP_775913.2 | |
RIMKLA | XM_006710585.4 | c.121C>G | p.Leu41Val | missense_variant | 1/5 | XP_006710648.1 | ||
RIMKLA | XM_047418484.1 | c.-313C>G | 5_prime_UTR_variant | 1/6 | XP_047274440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIMKLA | ENST00000431473.4 | c.121C>G | p.Leu41Val | missense_variant | 1/5 | 1 | NM_173642.4 | ENSP00000414330 | P1 | |
RIMKLA | ENST00000410070.6 | c.-313C>G | 5_prime_UTR_variant | 1/5 | 3 | ENSP00000387064 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000258 AC: 3AN: 1162530Hom.: 0 Cov.: 29 AF XY: 0.00000536 AC XY: 3AN XY: 559950
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2022 | The c.121C>G (p.L41V) alteration is located in exon 1 (coding exon 1) of the RIMKLA gene. This alteration results from a C to G substitution at nucleotide position 121, causing the leucine (L) at amino acid position 41 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at